Boehringer Ingelheim Finland joins Radical Health Festival Helsinki 2026 as Silver Partner
Boehringer Ingelheim Finland has joined Radical Health Festival Helsinki 2026 as a Silver Partner, supporting the Festival’s focus on precision health, value-based care, and system-level transformation across European health systems.
Radical Health Festival Helsinki 2026 takes place from 19 to 21 January at Messukeskus and is Europe’s Premier Festival for Health and Care. Co-curated with the Finnish Ministry of Social Affairs and Health and the City of Helsinki, the Festival brings together policymakers, clinicians, public authorities, innovators, investors, and industry leaders to focus on Operationalising Precision Health in real-world systems.
“As a family-owned pharmaceutical company, Boehringer Ingelheim is committed to creating long-term value for patients and society. We believe the future of healthcare lies in precision and value-based care, built on trust and collaboration. The Radical Health Festival provides an exceptional platform to turn these principles into action, and we are proud to contribute to shaping a healthier future and to discuss the path forward for chronic diseases – undiagnosed and untreated,” said Dr. Angela Peiter, Medical Director Finland.
Building on previous editions that brought together participants from more than 35 countries, Radical Health Festival Helsinki 2026 will welcome international delegations from ministries, regions, hospitals, and public health institutes, alongside innovators and industry leaders. The Festival is designed as a collaborative space focused on implementation, evidence-based dialogue, and system-level impact.
⸻
About Radical Health Festival Helsinki
Radical Health Festival Helsinki is Europe’s Premier Festival for Health and Care. Co-curated with the Finnish Ministry of Social Affairs and Health and the City of Helsinki, the Festival gathers leaders from across the health ecosystem to advance collaboration and progress toward more resilient and connected health systems.
⸻
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. The company’s approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com.
⸻
Media contacts
Radical Health Festival Helsinki
Sean Roberts (English-language media)
Strategic Relations Officer, Editohealth
Email: sean@editohealth.org
Boehringer Ingelheim Finland
Annakaisa Tirronen
Medical Team Lead
Email: annakaisa.tirronen@boehringer-ingelheim.com
Messukeskus
Irina Liimatainen
Marketing and communication specialist
Email: ext-irina.liimatainen@messukeskus.com
